Antibody Therapy Effective in Immunodeficient COVID-19 Patients

Patients with immunodeficiency-associated antibody disorders and a longstanding SARS-CoV-2 infection improved substantially after receiving compassionate-use casirivimab and imdevimab, a new study shows.
Reuters Health Information

source https://www.medscape.com/viewarticle/966136?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?